Comparison of Forced-Air and Warm Circulating-Water Warming for Prevention of Hypothermia and Blood Product Utilization During Open Cardiac Surgery
To the Editor:
PERIOPERATIVE HYPOTHERMIA, as defined by the Surgical Care Improvement Project as core temperature <36.0˚C is well-known to be associated with multiple complications, such as delayed wound healing, increased surgical site infection, prolonged length of stay, delayed recovery from anesthesia, negative nitrogen balance, and increased postoperative discomfort. 1À5 Other hypothermia-related complications more applicable to patients undergoing cardiac surgery are impaired platelet aggregation and coagulopathy; increased intraoperative blood loss and need for transfusion; increased risk of cardiac events (arrhythmias, myocardial infarction); and an overall higher mortality.
6À10 Indeed, postoperative hypothermia has been associated with increased mortality, prolonged mechanical ventilation, increased risk of packed red blood cell transfusion, and length of stay in cardiac surgery patients. 11 To address this problem, a wide range of active rewarming devices currently are available, with the convective forced-air warming blankets being the most widely adopted and best characterized in the literature.
12À14 Recognizing hypothermia to be a problem in approximately one-third of our cardiac surgery patients despite the use of a convective forced-air warming device (Bair Hugger; 3M, Maplewood, MN), we chose to investigate the conductive, warm waterÀcir-culating device (Allon ThermoWrap; Belmont Medical Technologies, Billerica, MA) at Tufts Medical Center in Boston.
As part of a quality improvement project, we initially investigated the use of a conductive, warm waterÀcirculating device in our patients undergoing transcatheter aortic valve replacement with general anesthesia. We believed that this cohort of patients represented a relatively homogenous sample with less intraprocedural variation. We found that the use of a conductive, warm waterÀcirculating device resulted in significantly higher core intraoperative temperatures on arrival to the intensive care unit compared with the underbody convective forced-air warming device. The details of this study are published elsewhere. 15 Results of our initial investigation lead us to expand our quality improvement initiative to open cardiac surgery patients. We conducted a retrospective analysis of patients who underwent elective coronary artery bypass grafting and valve procedures with the use of a convective forcedair warming device and compared postoperative temperatures with those of patients who were treated with the conductive, warm waterÀcirculating device. A total of 249 patients were included in our study, 117 and 132 for forced-air and watercirculating warming devices, respectively. The lowest temperatures recorded during cardiopulmonary bypass were not statistically different (33.8 § 1.4˚C v 34.0 § 1.6˚C; p = 0.24). Overall, the incidence of postoperative hypothermia was lower with the conductive, warm waterÀcirculating device compared with the forced-air device (7.6% v 29.9%; p < 0.0001).
Mean postoperative temperatures were higher with the watercirculating device (36.7 § 0.6˚C v 36.2 § 0.7˚C; p < 0.001) as well. Importantly, the rate of temperatures <35˚C was less in patients treated with the conductive, warm waterÀcirculat-ing device compared with that of patients treated with the convective forced-air warming device (0.8% v 6.8%; p < 0.0001).
The risk of receiving a unit of fresh frozen plasma was noted to be lower in the conductive, warm waterÀcirculating device group (0.20 v 0.33; p = 0.03). Although there was a trend toward a lower risk of transfusion of other blood components in the group warmed by the water-circulating device, a statistically significant difference was not observed (red blood cells 0. (Table 1) . Even though our quality improvement analysis was limited by the use of a historical control and thus propensity matching was not possible, our institutional review drove our decision to adopt the conductive, warmÀwater circulating device for 100% of our cardiac cases.
For administrative reasons, we did not have access to the conductive, warm waterÀcirculating device and returned to using the convective forced-air warming device for a period of time. This functioned effectively as a discontinuation trial. Additional data analysis of patients who underwent surgery during that period showed that, again, approximately 29% (15 of 52) experienced hypothermia on arrival to the intensive care unit. When compared with 132 patients who underwent surgery with the water-circulating device in the past, we found higher final intraoperative temperatures (37.1 § 0.6˚C v 36.5 § 0.6˚C; p < 0.001) and intensive care unit arrival temperatures (36.7 § 0.6˚C v 36.2 § 0.7˚C; p < 0.001) in the watercirculating group (Table 2) . Our institutional experience with the conductive, warm waterÀcirculating device is consistent with other reports in the literature. 16À18 Reduced transfusion requirements in off-pump coronary artery bypass grafting have been observed in patients warmed with the conductive, warm waterÀcirculating device. 19 Even mild hypothermia (34-36˚C) has been shown to increase blood loss by approximately 16% and the relative risk of transfusion by approximately 22%. 20 When considering the risks associated with transfusion of blood products, such as increased infection, ischemic morbidity, hospital costs, and mortality, the importance of this issue becomes rather clear. 21À23 We currently are reviewing data again with the hopes of having sufficient statistical power to study the effect of the conductive, warm waterÀcir-culating device on transfusion of blood products.
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